Viewing Study NCT00031733


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2025-12-26 @ 1:40 AM
Study NCT ID: NCT00031733
Status: COMPLETED
Last Update Posted: 2014-05-22
First Post: 2002-03-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
Sponsor: University of Southern California
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module